Share Price and Basic Stock Data
Last Updated: November 6, 2025, 9:45 pm
| PEG Ratio | -3.85 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
NOCIL Ltd operates in the petrochemicals sector, specifically focusing on polymers. As of the latest market data, the company’s share price stood at ₹183, with a market capitalization of ₹3,052 Cr. Over the fiscal years reported, NOCIL’s sales showed fluctuations, with a notable increase from ₹1,571 Cr in FY 2022 to ₹1,617 Cr in FY 2023, before declining to ₹1,445 Cr in FY 2024. The trailing twelve months (TTM) revenue was reported at ₹1,357 Cr. Quarterly sales figures have also exhibited variability; for instance, sales in June 2023 were reported at ₹397 Cr, while in September 2023, they dropped to ₹351 Cr. Such trends reflect the challenges faced in maintaining consistent revenue growth in a competitive market. The company’s operational performance is further illustrated by its quarterly operating profit margins, which ranged between 8% and 20% over the past few years, highlighting the pressures of cost management and pricing strategies in the fluctuating petrochemical market.
Profitability and Efficiency Metrics
NOCIL’s profitability metrics reveal a mixed performance in recent years. The company’s net profit for FY 2023 was recorded at ₹149 Cr, which declined slightly to ₹133 Cr in FY 2024. The net profit margin for FY 2025 stood at 7.38%, down from 9.20% in FY 2024, indicating challenges in profitability amidst rising costs. The operating profit margin (OPM) has also shown a downward trend, declining from 18% in FY 2022 to 10% in FY 2025. Efficiency metrics such as Return on Equity (ROE) and Return on Capital Employed (ROCE) were reported at 5.94% and 6.65%, respectively, both below typical industry averages, suggesting that NOCIL may not be fully optimizing its capital. Moreover, the cash conversion cycle (CCC) stood at 156 days, indicating longer periods for converting investments into cash, which could strain liquidity and operational efficiency.
Balance Sheet Strength and Financial Ratios
NOCIL’s balance sheet reflects a relatively conservative leverage position, with total borrowings reported at ₹10 Cr against reserves of ₹1,595 Cr, indicating a strong financial foundation. The company’s debt-to-equity ratio remains low, enhancing its financial stability. The interest coverage ratio (ICR) was exceptionally high at 94.70x, suggesting that NOCIL is well-equipped to meet its interest obligations. Additionally, the company’s current ratio stood at 5.82, significantly above the typical benchmark of 1, indicating strong short-term liquidity. However, the decline in ROCE to 7% in FY 2025 raises concerns regarding the efficiency of capital use. The price-to-book value ratio of 1.66x suggests that the stock is trading at a reasonable valuation compared to its book value, potentially appealing to value-focused investors.
Shareholding Pattern and Investor Confidence
The shareholding pattern of NOCIL Ltd indicates a stable ownership structure, with promoters holding 33.76% of the shares as of March 2025. Foreign Institutional Investors (FIIs) have increased their stake to 8.15%, reflecting growing confidence from international investors. Domestic Institutional Investors (DIIs) have seen a slight decline in their holdings to 5.33%, which could signal caution among local institutional investors. The public holds a significant portion of shares at 54.39%, indicating a broad base of retail investor participation. The total number of shareholders stood at 1,65,648, reflecting a diverse investor base. This distribution may enhance market liquidity, although the decline in DII participation could be a point of concern for long-term stability. The investor sentiment appears mixed, with the stock trading at a P/E ratio of 32.8, which could be perceived as high relative to industry norms, suggesting a premium valuation amidst the company’s profit pressures.
Outlook, Risks, and Final Insight
NOCIL Ltd faces several strengths and risks that could shape its future performance. On the positive side, the company’s low debt levels and robust interest coverage position it favorably against financial risks. Additionally, the increasing interest from FIIs suggests potential for future capital inflows. Conversely, the declining profitability metrics and high cash conversion cycle pose significant operational challenges that could hinder growth. Moreover, external factors such as fluctuations in raw material prices and competitive pressures in the petrochemical sector could impact NOCIL’s margins. Looking ahead, the company must focus on enhancing operational efficiency and managing costs to improve profitability. If NOCIL can stabilize its revenue and leverage its strong balance sheet, it may be well-positioned to navigate the challenges ahead. However, failure to address these operational issues could lead to further declines in investor confidence and market performance.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of NOCIL Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Hindustan Fluoro Carbons Ltd | 31.7 Cr. | 16.2 | 19.6/10.8 | 70.5 | 42.0 | 0.00 % | 1.02 % | % | 10.0 |
| Gujarat Petrosynthese Ltd | 37.3 Cr. | 62.4 | 81.5/52.1 | 17.2 | 83.6 | 0.00 % | 4.45 % | 2.93 % | 10.0 |
| AVI Polymers Ltd | 5.40 Cr. | 13.2 | 20.7/9.89 | 6.76 | 13.9 | 0.00 % | 19.4 % | 15.6 % | 10.0 |
| Supreme Petrochem Ltd | 12,505 Cr. | 667 | 982/518 | 40.7 | 118 | 1.50 % | 22.8 % | 17.4 % | 2.00 |
| Signet Industries Ltd | 161 Cr. | 56.0 | 81.8/39.0 | 7.98 | 79.5 | 0.89 % | 13.7 % | 6.88 % | 10.0 |
| Industry Average | 3,905.00 Cr | 181.37 | 37.32 | 81.73 | 0.83% | 14.57% | 13.10% | 7.55 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 509 | 389 | 326 | 393 | 397 | 351 | 341 | 356 | 372 | 363 | 318 | 340 | 336 |
| Expenses | 406 | 327 | 288 | 343 | 341 | 306 | 292 | 312 | 331 | 325 | 294 | 305 | 306 |
| Operating Profit | 103 | 62 | 38 | 50 | 56 | 45 | 49 | 45 | 41 | 38 | 24 | 34 | 31 |
| OPM % | 20% | 16% | 12% | 13% | 14% | 13% | 14% | 13% | 11% | 10% | 8% | 10% | 9% |
| Other Income | 0 | 1 | 2 | 3 | 5 | 5 | 6 | 25 | 9 | 8 | 9 | 6 | 7 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 |
| Depreciation | 14 | 14 | 14 | 14 | 13 | 13 | 13 | 13 | 13 | 13 | 14 | 13 | 14 |
| Profit before tax | 90 | 49 | 25 | 39 | 47 | 37 | 41 | 56 | 37 | 32 | 19 | 26 | 23 |
| Tax % | 26% | 26% | 26% | 26% | 27% | 26% | 26% | 25% | 26% | -30% | 32% | 20% | 25% |
| Net Profit | 66 | 36 | 19 | 28 | 34 | 27 | 30 | 42 | 27 | 42 | 13 | 21 | 17 |
| EPS in Rs | 3.99 | 2.14 | 1.12 | 1.70 | 2.06 | 1.63 | 1.80 | 2.49 | 1.62 | 2.52 | 0.77 | 1.24 | 1.03 |
Last Updated: August 20, 2025, 6:05 am
Below is a detailed analysis of the quarterly data for NOCIL Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 336.00 Cr.. The value appears to be declining and may need further review. It has decreased from 340.00 Cr. (Mar 2025) to 336.00 Cr., marking a decrease of 4.00 Cr..
- For Expenses, as of Jun 2025, the value is 306.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 305.00 Cr. (Mar 2025) to 306.00 Cr., marking an increase of 1.00 Cr..
- For Operating Profit, as of Jun 2025, the value is 31.00 Cr.. The value appears to be declining and may need further review. It has decreased from 34.00 Cr. (Mar 2025) to 31.00 Cr., marking a decrease of 3.00 Cr..
- For OPM %, as of Jun 2025, the value is 9.00%. The value appears to be declining and may need further review. It has decreased from 10.00% (Mar 2025) to 9.00%, marking a decrease of 1.00%.
- For Other Income, as of Jun 2025, the value is 7.00 Cr.. The value appears strong and on an upward trend. It has increased from 6.00 Cr. (Mar 2025) to 7.00 Cr., marking an increase of 1.00 Cr..
- For Interest, as of Jun 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Depreciation, as of Jun 2025, the value is 14.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 13.00 Cr. (Mar 2025) to 14.00 Cr., marking an increase of 1.00 Cr..
- For Profit before tax, as of Jun 2025, the value is 23.00 Cr.. The value appears to be declining and may need further review. It has decreased from 26.00 Cr. (Mar 2025) to 23.00 Cr., marking a decrease of 3.00 Cr..
- For Tax %, as of Jun 2025, the value is 25.00%. The value appears to be increasing, which may not be favorable. It has increased from 20.00% (Mar 2025) to 25.00%, marking an increase of 5.00%.
- For Net Profit, as of Jun 2025, the value is 17.00 Cr.. The value appears to be declining and may need further review. It has decreased from 21.00 Cr. (Mar 2025) to 17.00 Cr., marking a decrease of 4.00 Cr..
- For EPS in Rs, as of Jun 2025, the value is 1.03. The value appears to be declining and may need further review. It has decreased from 1.24 (Mar 2025) to 1.03, marking a decrease of 0.21.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: August 23, 2025, 2:22 pm
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 596 | 719 | 715 | 742 | 964 | 1,043 | 846 | 925 | 1,571 | 1,617 | 1,445 | 1,393 | 1,357 |
| Expenses | 534 | 605 | 575 | 582 | 695 | 750 | 668 | 793 | 1,284 | 1,364 | 1,250 | 1,255 | 1,230 |
| Operating Profit | 62 | 114 | 140 | 160 | 269 | 293 | 178 | 132 | 288 | 253 | 195 | 137 | 127 |
| OPM % | 10% | 16% | 20% | 22% | 28% | 28% | 21% | 14% | 18% | 16% | 14% | 10% | 9% |
| Other Income | 9 | 3 | 3 | 9 | 11 | 10 | 9 | 14 | 2 | 6 | 39 | 32 | 30 |
| Interest | 17 | 17 | 9 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 |
| Depreciation | 19 | 14 | 15 | 20 | 24 | 24 | 34 | 37 | 48 | 56 | 53 | 54 | 54 |
| Profit before tax | 35 | 86 | 119 | 147 | 255 | 278 | 152 | 107 | 241 | 202 | 180 | 114 | 101 |
| Tax % | 32% | 34% | 34% | 34% | 33% | 33% | 14% | 17% | 27% | 26% | 26% | 10% | |
| Net Profit | 24 | 57 | 78 | 97 | 170 | 185 | 131 | 88 | 176 | 149 | 133 | 103 | 93 |
| EPS in Rs | 1.48 | 3.55 | 4.87 | 5.94 | 10.33 | 11.17 | 7.89 | 5.32 | 10.57 | 8.95 | 7.98 | 6.16 | 5.56 |
| Dividend Payout % | 40% | 28% | 25% | 30% | 24% | 22% | 32% | 38% | 28% | 34% | 38% | 32% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 137.50% | 36.84% | 24.36% | 75.26% | 8.82% | -29.19% | -32.82% | 100.00% | -15.34% | -10.74% | -22.56% |
| Change in YoY Net Profit Growth (%) | 0.00% | -100.66% | -12.48% | 50.90% | -66.43% | -38.01% | -3.64% | 132.82% | -115.34% | 4.60% | -11.82% |
NOCIL Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 7% |
| 5 Years: | 10% |
| 3 Years: | -4% |
| TTM: | -4% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 6% |
| 5 Years: | -4% |
| 3 Years: | -16% |
| TTM: | -26% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 17% |
| 5 Years: | 8% |
| 3 Years: | -13% |
| 1 Year: | -37% |
| Return on Equity | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 8% |
| 3 Years: | 8% |
| Last Year: | 6% |
Last Updated: September 5, 2025, 11:45 am
Balance Sheet
Last Updated: June 16, 2025, 11:37 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 161 | 161 | 161 | 164 | 164 | 165 | 166 | 166 | 167 | 167 | 167 | 167 |
| Reserves | 217 | 254 | 309 | 750 | 882 | 998 | 1,020 | 1,119 | 1,279 | 1,385 | 1,532 | 1,595 |
| Borrowings | 152 | 147 | 26 | 15 | 5 | 0 | 7 | 6 | 6 | 10 | 13 | 10 |
| Other Liabilities | 203 | 193 | 186 | 233 | 279 | 279 | 250 | 324 | 380 | 295 | 304 | 284 |
| Total Liabilities | 732 | 755 | 682 | 1,161 | 1,331 | 1,442 | 1,442 | 1,615 | 1,830 | 1,857 | 2,015 | 2,057 |
| Fixed Assets | 320 | 311 | 307 | 543 | 528 | 657 | 797 | 918 | 909 | 888 | 870 | 855 |
| CWIP | 3 | 3 | 6 | 4 | 42 | 131 | 156 | 14 | 8 | 9 | 16 | 60 |
| Investments | 22 | 22 | 22 | 176 | 281 | 130 | 54 | 68 | 53 | 218 | 399 | 366 |
| Other Assets | 386 | 418 | 347 | 438 | 480 | 524 | 434 | 614 | 859 | 742 | 730 | 776 |
| Total Assets | 732 | 755 | 682 | 1,161 | 1,331 | 1,442 | 1,442 | 1,615 | 1,830 | 1,857 | 2,015 | 2,057 |
Below is a detailed analysis of the balance sheet data for NOCIL Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 167.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 167.00 Cr..
- For Reserves, as of Mar 2025, the value is 1,595.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,532.00 Cr. (Mar 2024) to 1,595.00 Cr., marking an increase of 63.00 Cr..
- For Borrowings, as of Mar 2025, the value is 10.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 13.00 Cr. (Mar 2024) to 10.00 Cr., marking a decrease of 3.00 Cr..
- For Other Liabilities, as of Mar 2025, the value is 284.00 Cr.. The value appears to be improving (decreasing). It has decreased from 304.00 Cr. (Mar 2024) to 284.00 Cr., marking a decrease of 20.00 Cr..
- For Total Liabilities, as of Mar 2025, the value is 2,057.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2,015.00 Cr. (Mar 2024) to 2,057.00 Cr., marking an increase of 42.00 Cr..
- For Fixed Assets, as of Mar 2025, the value is 855.00 Cr.. The value appears to be declining and may need further review. It has decreased from 870.00 Cr. (Mar 2024) to 855.00 Cr., marking a decrease of 15.00 Cr..
- For CWIP, as of Mar 2025, the value is 60.00 Cr.. The value appears strong and on an upward trend. It has increased from 16.00 Cr. (Mar 2024) to 60.00 Cr., marking an increase of 44.00 Cr..
- For Investments, as of Mar 2025, the value is 366.00 Cr.. The value appears to be declining and may need further review. It has decreased from 399.00 Cr. (Mar 2024) to 366.00 Cr., marking a decrease of 33.00 Cr..
- For Other Assets, as of Mar 2025, the value is 776.00 Cr.. The value appears strong and on an upward trend. It has increased from 730.00 Cr. (Mar 2024) to 776.00 Cr., marking an increase of 46.00 Cr..
- For Total Assets, as of Mar 2025, the value is 2,057.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,015.00 Cr. (Mar 2024) to 2,057.00 Cr., marking an increase of 42.00 Cr..
Notably, the Reserves (1,595.00 Cr.) exceed the Borrowings (10.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -90.00 | -33.00 | 114.00 | 145.00 | 264.00 | 293.00 | 171.00 | 126.00 | 282.00 | 243.00 | 182.00 | 127.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 90 | 85 | 77 | 82 | 92 | 81 | 88 | 122 | 104 | 78 | 86 | 81 |
| Inventory Days | 167 | 176 | 135 | 116 | 129 | 133 | 128 | 120 | 141 | 117 | 100 | 129 |
| Days Payable | 122 | 79 | 74 | 82 | 96 | 77 | 84 | 123 | 91 | 52 | 53 | 54 |
| Cash Conversion Cycle | 136 | 182 | 138 | 116 | 125 | 138 | 132 | 119 | 154 | 143 | 133 | 156 |
| Working Capital Days | 57 | 71 | 86 | 86 | 94 | 99 | 104 | 114 | 128 | 108 | 110 | 194 |
| ROCE % | 10% | 19% | 24% | 21% | 26% | 25% | 13% | 9% | 18% | 13% | 10% | 7% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| Canara Robeco Small Cap Fund | 1,085,617 | 0.26 | 27.48 | 1,085,617 | 2025-04-22 17:25:24 | 0% |
| Aditya Birla Sun Life Business Cycle Fund | 841,512 | 1.25 | 21.3 | 841,512 | 2025-04-22 17:25:24 | 0% |
| HSBC Value Fund | 776,500 | 0.16 | 19.65 | 776,500 | 2025-04-22 17:25:24 | 0% |
| Edelweiss Small Cap Fund | 771,979 | 0.57 | 19.54 | 771,979 | 2025-04-22 17:25:24 | 0% |
| Bandhan Small Cap Fund | 485,631 | 0.24 | 12.29 | 485,631 | 2025-04-22 17:25:24 | 0% |
| Canara Robeco Manufacturing Fund | 453,736 | 0.84 | 11.48 | 453,736 | 2025-04-22 17:25:24 | 0% |
| Aditya Birla Sun Life Manufacturing Equity Fund | 286,652 | 0.72 | 7.26 | 286,652 | 2025-04-22 17:25:24 | 0% |
| Taurus ELSS Tax Saver Fund | 38,665 | 1.31 | 0.98 | 38,665 | 2025-04-22 17:25:24 | 0% |
| IDBI Hybrid Equity Fund | 32,613 | 0.4 | 0.72 | 32,613 | 2025-04-22 17:25:24 | 0% |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 6.17 | 7.98 | 8.95 | 10.58 | 5.33 |
| Diluted EPS (Rs.) | 6.15 | 7.95 | 8.92 | 10.55 | 5.32 |
| Cash EPS (Rs.) | 9.37 | 11.15 | 12.29 | 13.47 | 7.57 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 105.51 | 101.92 | 93.14 | 86.76 | 77.29 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 105.51 | 101.92 | 93.14 | 86.76 | 77.29 |
| Revenue From Operations / Share (Rs.) | 83.38 | 86.69 | 97.01 | 94.33 | 55.63 |
| PBDIT / Share (Rs.) | 10.15 | 14.07 | 15.54 | 17.41 | 8.76 |
| PBIT / Share (Rs.) | 6.94 | 10.90 | 12.20 | 14.51 | 6.50 |
| PBT / Share (Rs.) | 6.83 | 10.80 | 12.13 | 14.45 | 6.45 |
| Net Profit / Share (Rs.) | 6.16 | 7.98 | 8.95 | 10.57 | 5.32 |
| NP After MI And SOA / Share (Rs.) | 6.16 | 7.98 | 8.95 | 10.57 | 5.32 |
| PBDIT Margin (%) | 12.17 | 16.22 | 16.01 | 18.45 | 15.73 |
| PBIT Margin (%) | 8.32 | 12.57 | 12.57 | 15.38 | 11.69 |
| PBT Margin (%) | 8.19 | 12.45 | 12.50 | 15.31 | 11.58 |
| Net Profit Margin (%) | 7.38 | 9.20 | 9.22 | 11.20 | 9.56 |
| NP After MI And SOA Margin (%) | 7.38 | 9.20 | 9.22 | 11.20 | 9.56 |
| Return on Networth / Equity (%) | 5.83 | 7.83 | 9.60 | 12.18 | 6.88 |
| Return on Capital Employeed (%) | 6.11 | 9.81 | 12.05 | 15.38 | 7.69 |
| Return On Assets (%) | 5.00 | 6.59 | 8.03 | 9.62 | 5.47 |
| Asset Turnover Ratio (%) | 0.68 | 0.74 | 0.88 | 0.91 | 0.60 |
| Current Ratio (X) | 5.82 | 5.89 | 5.15 | 3.25 | 2.96 |
| Quick Ratio (X) | 4.07 | 4.55 | 3.49 | 1.97 | 2.17 |
| Inventory Turnover Ratio (X) | 5.53 | 5.69 | 2.94 | 3.79 | 3.17 |
| Dividend Payout Ratio (NP) (%) | 48.60 | 37.58 | 33.50 | 18.89 | 0.00 |
| Dividend Payout Ratio (CP) (%) | 31.96 | 26.90 | 24.40 | 14.82 | 0.00 |
| Earning Retention Ratio (%) | 51.40 | 62.42 | 66.50 | 81.11 | 0.00 |
| Cash Earning Retention Ratio (%) | 68.04 | 73.10 | 75.60 | 85.18 | 0.00 |
| Interest Coverage Ratio (X) | 94.70 | 144.69 | 215.81 | 266.10 | 150.03 |
| Interest Coverage Ratio (Post Tax) (X) | 58.46 | 83.10 | 125.29 | 162.57 | 92.14 |
| Enterprise Value (Cr.) | 2887.72 | 4059.04 | 3380.38 | 4139.10 | 2821.79 |
| EV / Net Operating Revenue (X) | 2.07 | 2.81 | 2.09 | 2.63 | 3.05 |
| EV / EBITDA (X) | 17.04 | 17.32 | 13.05 | 14.27 | 19.39 |
| MarketCap / Net Operating Revenue (X) | 2.10 | 2.88 | 2.13 | 2.64 | 3.14 |
| Retention Ratios (%) | 51.39 | 62.41 | 66.49 | 81.10 | 0.00 |
| Price / BV (X) | 1.66 | 2.45 | 2.21 | 2.88 | 2.26 |
| Price / Net Operating Revenue (X) | 2.10 | 2.88 | 2.13 | 2.64 | 3.14 |
| EarningsYield | 0.03 | 0.03 | 0.04 | 0.04 | 0.03 |
After reviewing the key financial ratios for NOCIL Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 6.17. This value is within the healthy range. It has decreased from 7.98 (Mar 24) to 6.17, marking a decrease of 1.81.
- For Diluted EPS (Rs.), as of Mar 25, the value is 6.15. This value is within the healthy range. It has decreased from 7.95 (Mar 24) to 6.15, marking a decrease of 1.80.
- For Cash EPS (Rs.), as of Mar 25, the value is 9.37. This value is within the healthy range. It has decreased from 11.15 (Mar 24) to 9.37, marking a decrease of 1.78.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 105.51. It has increased from 101.92 (Mar 24) to 105.51, marking an increase of 3.59.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 105.51. It has increased from 101.92 (Mar 24) to 105.51, marking an increase of 3.59.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 83.38. It has decreased from 86.69 (Mar 24) to 83.38, marking a decrease of 3.31.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 10.15. This value is within the healthy range. It has decreased from 14.07 (Mar 24) to 10.15, marking a decrease of 3.92.
- For PBIT / Share (Rs.), as of Mar 25, the value is 6.94. This value is within the healthy range. It has decreased from 10.90 (Mar 24) to 6.94, marking a decrease of 3.96.
- For PBT / Share (Rs.), as of Mar 25, the value is 6.83. This value is within the healthy range. It has decreased from 10.80 (Mar 24) to 6.83, marking a decrease of 3.97.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 6.16. This value is within the healthy range. It has decreased from 7.98 (Mar 24) to 6.16, marking a decrease of 1.82.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 6.16. This value is within the healthy range. It has decreased from 7.98 (Mar 24) to 6.16, marking a decrease of 1.82.
- For PBDIT Margin (%), as of Mar 25, the value is 12.17. This value is within the healthy range. It has decreased from 16.22 (Mar 24) to 12.17, marking a decrease of 4.05.
- For PBIT Margin (%), as of Mar 25, the value is 8.32. This value is below the healthy minimum of 10. It has decreased from 12.57 (Mar 24) to 8.32, marking a decrease of 4.25.
- For PBT Margin (%), as of Mar 25, the value is 8.19. This value is below the healthy minimum of 10. It has decreased from 12.45 (Mar 24) to 8.19, marking a decrease of 4.26.
- For Net Profit Margin (%), as of Mar 25, the value is 7.38. This value is within the healthy range. It has decreased from 9.20 (Mar 24) to 7.38, marking a decrease of 1.82.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 7.38. This value is below the healthy minimum of 8. It has decreased from 9.20 (Mar 24) to 7.38, marking a decrease of 1.82.
- For Return on Networth / Equity (%), as of Mar 25, the value is 5.83. This value is below the healthy minimum of 15. It has decreased from 7.83 (Mar 24) to 5.83, marking a decrease of 2.00.
- For Return on Capital Employeed (%), as of Mar 25, the value is 6.11. This value is below the healthy minimum of 10. It has decreased from 9.81 (Mar 24) to 6.11, marking a decrease of 3.70.
- For Return On Assets (%), as of Mar 25, the value is 5.00. This value is within the healthy range. It has decreased from 6.59 (Mar 24) to 5.00, marking a decrease of 1.59.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.68. It has decreased from 0.74 (Mar 24) to 0.68, marking a decrease of 0.06.
- For Current Ratio (X), as of Mar 25, the value is 5.82. This value exceeds the healthy maximum of 3. It has decreased from 5.89 (Mar 24) to 5.82, marking a decrease of 0.07.
- For Quick Ratio (X), as of Mar 25, the value is 4.07. This value exceeds the healthy maximum of 2. It has decreased from 4.55 (Mar 24) to 4.07, marking a decrease of 0.48.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 5.53. This value is within the healthy range. It has decreased from 5.69 (Mar 24) to 5.53, marking a decrease of 0.16.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 48.60. This value is within the healthy range. It has increased from 37.58 (Mar 24) to 48.60, marking an increase of 11.02.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 31.96. This value is within the healthy range. It has increased from 26.90 (Mar 24) to 31.96, marking an increase of 5.06.
- For Earning Retention Ratio (%), as of Mar 25, the value is 51.40. This value is within the healthy range. It has decreased from 62.42 (Mar 24) to 51.40, marking a decrease of 11.02.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 68.04. This value is within the healthy range. It has decreased from 73.10 (Mar 24) to 68.04, marking a decrease of 5.06.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 94.70. This value is within the healthy range. It has decreased from 144.69 (Mar 24) to 94.70, marking a decrease of 49.99.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 58.46. This value is within the healthy range. It has decreased from 83.10 (Mar 24) to 58.46, marking a decrease of 24.64.
- For Enterprise Value (Cr.), as of Mar 25, the value is 2,887.72. It has decreased from 4,059.04 (Mar 24) to 2,887.72, marking a decrease of 1,171.32.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 2.07. This value is within the healthy range. It has decreased from 2.81 (Mar 24) to 2.07, marking a decrease of 0.74.
- For EV / EBITDA (X), as of Mar 25, the value is 17.04. This value exceeds the healthy maximum of 15. It has decreased from 17.32 (Mar 24) to 17.04, marking a decrease of 0.28.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 2.10. This value is within the healthy range. It has decreased from 2.88 (Mar 24) to 2.10, marking a decrease of 0.78.
- For Retention Ratios (%), as of Mar 25, the value is 51.39. This value is within the healthy range. It has decreased from 62.41 (Mar 24) to 51.39, marking a decrease of 11.02.
- For Price / BV (X), as of Mar 25, the value is 1.66. This value is within the healthy range. It has decreased from 2.45 (Mar 24) to 1.66, marking a decrease of 0.79.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 2.10. This value is within the healthy range. It has decreased from 2.88 (Mar 24) to 2.10, marking a decrease of 0.78.
- For EarningsYield, as of Mar 25, the value is 0.03. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.03.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in NOCIL Ltd:
- Net Profit Margin: 7.38%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 6.11% (Industry Average ROCE: 14.57%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 5.83% (Industry Average ROE: 13.1%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 58.46
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 4.07
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 46.4 (Industry average Stock P/E: 37.32)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 7.38%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Petrochemicals - Polymers | Mafatlal House, H T Parekh Marg, Mumbai Maharashtra 400020 | investorcare@nocil.com http://www.nocil.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Hrishikesh A Mafatlal | Executive Chairman |
| Mr. Anand V S | Managing Director |
| Mr. Priyavrata H Mafatlal | Non Independent Director |
| Mr. Vilas R Gupte | Independent Director |
| Mr. Debnarayan Bhattacharya | Independent Director |
| Mr. A Vellayan | Independent Director |
| Mr. Sujal Shah | Independent Director |
| Mr. Ramesh Iyer | Independent Director |
| Ms. Radhika Haribhakti | Independent Director |
FAQ
What is the intrinsic value of NOCIL Ltd?
NOCIL Ltd's intrinsic value (as of 06 November 2025) is 236.39 which is 34.31% higher the current market price of 176.00, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's 2,928 Cr. market cap, FY2025-2026 high/low of 294/155, reserves of ₹1,595 Cr, and liabilities of 2,057 Cr.
What is the Market Cap of NOCIL Ltd?
The Market Cap of NOCIL Ltd is 2,928 Cr..
What is the current Stock Price of NOCIL Ltd as on 06 November 2025?
The current stock price of NOCIL Ltd as on 06 November 2025 is 176.
What is the High / Low of NOCIL Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of NOCIL Ltd stocks is 294/155.
What is the Stock P/E of NOCIL Ltd?
The Stock P/E of NOCIL Ltd is 46.4.
What is the Book Value of NOCIL Ltd?
The Book Value of NOCIL Ltd is 106.
What is the Dividend Yield of NOCIL Ltd?
The Dividend Yield of NOCIL Ltd is 1.14 %.
What is the ROCE of NOCIL Ltd?
The ROCE of NOCIL Ltd is 6.65 %.
What is the ROE of NOCIL Ltd?
The ROE of NOCIL Ltd is 5.94 %.
What is the Face Value of NOCIL Ltd?
The Face Value of NOCIL Ltd is 10.0.